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The striatum is key for action-selection and the motivation to move. Dopamine
and acetylcholine release sites are enriched in the striatum and are cross-regulated,
possibly to achieve optimal behavior. Drugs of abuse, which promote abnormally
high dopamine release, disrupt normal action-selection and drive restricted, repetitive
behaviors (stereotypies). Stereotypies occur in a variety of disorders including
obsessive-compulsive disorder, autism, schizophrenia and Huntington’s disease, as well
as in addictive states. The severity of drug-induced stereotypy is correlated with induction
of c-Fos expression in striosomes, a striatal compartment that is related to the limbic
system and that directly projects to dopamine-producing neurons of the substantia nigra.
These characteristics of striosomes contrast with the properties of the extra-striosomal
matrix, which has strong sensorimotor and associative circuit inputs and outputs.
Disruption of acetylcholine signaling in the striatum blocks the striosome-predominant
c-Fos expression pattern induced by drugs of abuse and alters drug-induced stereotypy.
The activity of striatal cholinergic interneurons is associated with behaviors related to
sensory cues, and cortical inputs to striosomes can bias action-selection in the face
of conflicting cues. The neurons and neuropil of striosomes and matrix neurons have
observably separate distributions, both at the input level in the striatum and at the
output level in the substantia nigra. Notably, cholinergic axons readily cross compartment
borders, providing a potential route for local cross-compartment communication to
maintain a balance between striosomal and matrix activity. We show here, by slice
electrophysiology in transgenic mice, that repetitive evoked firing patterns in striosomal
and matrix striatal projection neurons (SPNs) are interrupted by optogenetic activation of
cholinergic interneurons either by the addition or the deletion of spikes. We demonstrate
that this cholinergic modulation of projection neurons is blocked in brain slices taken from
mice exposed to amphetamine and engaged in amphetamine-induced stereotypy, and
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lacking responsiveness to salient cues. Our findings support a model whereby activity
in striosomes is normally under strong regulation by cholinergic interneurons, favoring
behavioral flexibility, but that in animals with drug-induced stereotypy, this cholinergic
signaling breaks down, resulting in differential modulation of striosomal activity and an
inability to bias action-selection according to relevant sensory cues.
Keywords: striosome, striatum, amphetamine, stereotypy, cholinergic interneuron
INTRODUCTION
Pathologically repetitive and restricted behaviors, known as
stereotypies, occur in numerous disorders and are notably
difficult to disrupt, suggesting a failure in attention to
environmental cues that might normally direct a change in
behavior. Stereotypies can also be induced in humans and other
animals by high doses of habit-forming drugs such as cocaine and
amphetamine. Animals with drug-induced stereotypic behavior
exhibit high c-Fos immediate-early gene induction in striatal
projection neurons (SPNs) within the striosome compartment
of the striatum, relative to low activation in SPNs located in
the surrounding matrix compartment (Canales and Graybiel,
2000; Tan et al., 2000; Saka et al., 2004; Crittenden and
Graybiel, 2011, 2016; Horner et al., 2012; Jedynak et al.,
2012). Such differential c-Fos induction in striosomes, relative
to c-Fos induction in the matrix, is blocked by intrastriatal
ablation of cholinergic interneurons (referred to herein as
ChIs), along with somatostatin-expressing interneurons (Saka
et al., 2002), and manipulations of ChI signaling have a direct
impact on the severity of cocaine- and amphetamine-induced
stereotypies (Schoffelmeer et al., 2002; Collins and Izenwasser,
2004; Thomsen et al., 2010; Aliane et al., 2011; Crittenden
et al., 2014). High-dose drug treatments also are related to an
imbalance in activity of cortical regions that differentially project
to the striatal striosome or matrix compartment (Gerfen, 1984;
Kincaid and Wilson, 1996; Aliane et al., 2009; Friedman et al.,
2015; Kupferschmidt et al., 2015). All together, these findings
suggest that a balance in activity between striosome-based and
matrix-based cortico-basal ganglia loops could be critical for
behavioral flexibility.
In contrast to the widespread interconnections that occur
among the D1- and D2-dopamine receptor-positive SPNs
of the direct and indirect output pathways (Taverna et al.,
2008), SPNs that lie in the striosome or matrix compartments
seem particularly separated, not only physically but also
electrophysiologically (Kawaguchi et al., 1989; Banghart et al.,
2015; Lopez-Huerta et al., 2016), though with some cross-
compartment crossing of their processes (Bolam et al., 1988;
Walker et al., 1993). Striosomal SPNs give rise to a unique
striatonigral connection to subgroups of neurons in the
substantia nigra pars compacta that produce dopamine (Gerfen,
1985; Jimenez-Castellanos and Graybiel, 1989; Fujiyama et al.,
2011; Watabe-Uchida et al., 2012; Crittenden et al., 2016), a
neurotransmitter that is released by all known drugs of abuse
and is a key driver of motivated behaviors and movement
initiation (Schultz, 2011; Dodson et al., 2016; Howe and
Dombeck, 2016). Further, the striosome-targeted dopamine-
positive neurons project back both to striosomes and matrix,
suggesting a circuit by which striosomes could exert both
localized and global control over the dorsal striatum (Crittenden
et al., 2016). For technical reasons, few studies have addressed
how striosomal neurons are regulated, and striosomes are
difficult targets because they comprise only ∼15–20% of the
SPN populations, which primarily occupy the extrastriosomal
matrix that houses the cells of origin of the classic direct
and indirect basal ganglia pathways for motor control. Yet
striosomes are preferential targets of some cortical regions related
to the limbic system, and they target lateral habenula-linked
circuits and the dopamine-containing nigral pars compacta, both
implicated in motivation and reinforcement-driven behaviors.
Thus, striosomal SPNs, insofar as they act through their main
GABAergic neurotransmitter mechanism, are well placed to
counterbalance hyper-activation of the dopamine system.
The relative segregation of striosomal and matrix SPNs raises
the question of what mechanisms maintain the normal balance
of the striatal compartments, including the balanced expression
of immediate-early gene products, such as c-Fos, expression
that becomes striosome-predominant in animals exhibiting
drug-induced stereotypy. ChIs and other interneurons that are
located along the striosomal borders are leading candidates for
coordinating activity between the two compartments (Graybiel
et al., 1986; Sandell et al., 1986; Kubota and Kawaguchi, 1993;
Aosaki et al., 1995; Mounir and Parent, 2002; Miura et al., 2007;
Brimblecombe and Cragg, 2015). ChIs are thought to correspond
to the tonically active neurons of the striatum (TANs), which
respond to salient or instructive stimuli with an activation, pause
and rebound pattern of activity (Apicella et al., 1991; Aosaki
et al., 1995; Blazquez et al., 2002; Minamimoto and Kimura,
2002; Goldberg and Reynolds, 2011; Doig et al., 2014; Thorn
and Graybiel, 2014). This cue-response is semi-synchronized
among TANs across the striatum and is driven by input from
the neocortex and from the intralaminar nuclei of the thalamus,
which are themselves activated by sensory inputs (Aosaki et al.,
1995; Matsumoto et al., 2001; Morris et al., 2004; Brown
et al., 2010; Doig et al., 2014). Strategic switching behaviors
exhibited in learning tasks are impacted by manipulations of
ChIs in the striatum (Minamimoto et al., 2005; McCool et al.,
2008; Brown et al., 2010; Okada et al., 2014). The extreme
loss of behavioral flexibility that occurs in animals engaged in
drug-induced stereotypies is likewise modulated by cholinergic
manipulations (Schoffelmeer et al., 2002; Collins and Izenwasser,
2004; Thomsen et al., 2010; Aliane et al., 2011; Crittenden et al.,
2014). These findings suggest that thalamic and cortical input to
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the ChIs of the dorsal striatum helps to re-set motor systems to
modulate behavioral flexibility in the face of conflicting cues or
drug-induced overload of the dopamine system (Ding et al., 2010;
Minamimoto et al., 2014; Eskow Jaunarajs et al., 2015). Whether
striosomal and matrix SPNs are differentially controlled by ChIs,
however, has not been tested. We now have performed such a
test, and have specifically asked whether we could estimate the
ChIs modulation of SPN firing activity related to amphetamine-
induced stereotypies by examining SPN responses in slices
prepared from animals actively engaged in such behaviors.
It is known frommuch work on striatal slices that activation of
ChIs induces GABA release from local sources to drive inhibitory
responses in SPNs (Miura et al., 2006; English et al., 2012; Luo
et al., 2013; Nelson et al., 2014b; Faust et al., 2016). These
measurements have been made without identification of striatal
compartments, but likely were made mostly in the large matrix
compartment. Inoue and colleagues (Inoue et al., 2016) have now
identified striosomes in a brain slice recording preparation by
using young transgenicmice expressing green fluorescent protein
(GFP) under the control of the tyrosine hydroxylase promoter
(Matsushita et al., 2002), which is striosome-enriched in young
mice (<28 days of age). Paired neuronal recordings in these mice
demonstrated that SPNs, and other ChIs, can inhibit ChIs within
and across compartments (Inoue et al., 2016), consistent with the
fact that ChI neuropil crosses compartment borders (Graybiel
et al., 1986; Crittenden et al., 2014). Whether ChI activation
induces the prominent pause in activity in both striosomal and
matrix SPNs was not examined.
We performed slice recordings and optogenetic stimulation of
ChIs in double transgenic mice that have matrix-enriched GFP
and channelrhodopsin (ChR2) in ChIs. Wide-field application
of a blue light pulse to the slices induced a single spike in the
ChIs. We show here that this ChI stimulation produced a brief
inhibition of evoked, repetitive firing in both striosomal and
matrix SPNs. We also observed, in SPNs of both the matrix and
striosomes, that the optogenetic activation of ChIs occasionally
induced a spike-advance in the SPN firing pattern. All of these
effects were blocked by the nicotinic acetylcholine receptor
antagonist, dihydro-β-erythroidine (DHβE). Furthermore, in
brain slices taken from drug-treated transgenic mice engaged
in amphetamine-induced stereotypies and non-respondent to
salient cues, ChI stimulation failed to disrupt the evoked
repetitive striosomal and matrix SPN firing. These results raise
the proposal, favored here, that the loss of behavioral flexibility
that occurs in animals under the influence of psychomotor
stimulants could result from a failure in the ability of ChIs to
reset ongoing striatal activity and motor behavior in response to
relevant environmental cues.
MATERIALS AND METHODS
Mice
All procedures were approved by the Committee on Animal
Care at the Massachusetts Institute of Technology, which is
AAALAC accredited. Table 1 summarizes mouse lines used.
Double transgenic mice were generated from intercrosses of
single hemizygous mice so that no offspring were homozygous
for a transgene. ChAT-IRES-Cre knock-in mice (JAX stock
#006410) (Rossi et al., 2011) were on a mixed 129S6, C57Bl/6J
genetic background. Mice with the ChAT-ChR2-EYFP bacterial
artificial chromosome (BAC) (Zhao et al., 2011) were on a
C57Bl/6 genetic background. CalDAG-GEFI (aka RasGRP2)-
EGFP BAC mice (Gong et al., 2003) were on a FVB/N-
Swiss Webster hybrid background. For neuroanatomical studies,
ChAT-IRES-Cre knock-in mice were crossed to Ai32(RCL-
ChR2(H134R)/EYFP) knock-in mice (JAX stock #024109)
(Madisen et al., 2012) on a C57Bl/6 background. Experimental
mice were male, 2–6 months of age, and housed under a standard
light-dark cycle (lights on at 7 am and off at 7 pm), with
free access to food and water. Mice with intracerebral viral
injections were single-housed post-surgery, and mice that were
D-amphetamine-treated were single-housed. Otherwise mice
were group-housed with brothers.
Tissue Preparation, Immunolabeling, and
Microscopy
Mice were anesthetized with Euthasol (Virbac AH Inc.;
pentobarbital sodium and phenytoin sodium) and then
trans-cardially perfused with 0.9% saline, followed by 4%
paraformaldehyde in 0.1 M NaKPO4 buffer solution (PBS).
Brains were then dissected, post-fixed for 90 min, stored in
20% glycerin sinking solution overnight or longer, and cut
into transverse sections at 30µm on a freezing microtome.
Sections were stored in 0.1% sodium azide in 0.1 M PBS until
use. Free-floating sections were rinsed in 0.01 M PBS with
0.2% Triton X-100 and then were blocked in TSA Blocking
TABLE 1 | Transgenic mice used in this study.
Transgenic mouse line Description References
Single transgenic CalDAG-GEFI-GFP BAC EGFP is inserted in the CalDAG-GEFI (aka RasGRP2) BAC and is expressed
in matrix SPNs.
Gong et al., 2003; Crittenden et al., 2016
Double knock-in transgenic ChAT-Cre;Ai32 Cre is inserted in the choline acetyl transferase (ChAT) gene locus and is
expressed in ChIs. Cre-dependent EYFP is inserted in the Rosa 26 locus to
permit expression in most cell types that express Cre.
Rossi et al., 2011; Madisen et al., 2012
Double transgenic CalDAG-GEFI-GFP
BAC;ChAT-Cre knock-in
EGFP is expressed in matrix SPNs. ChR2 is expressed in ChIs by
intracerebral injection of a viral vector for Cre-dependent ChR2.
Gong et al., 2003; Rossi et al., 2011
Double BAC transgenic
CalDAG-GEFI-GFP;ChATChR2
EGFP is expressed in matrix SPNs. ChR2 is inserted in a BAC containing
the ChAT gene and is expressed in ChIs.
Zhao et al., 2011
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Reagent (Perkin Elmer) prior to incubation for 1 or 2 nights with
immunosera against GFP (Aves Lab, GFP-1020, 1:500 dilution),
yellow fluorescent protein (Abcam, Ab6556, 1:2,000 dilution),
mu-opioid receptor subtype 1 (MOR1) (Abcam, Ab134054, 1:500
dilution), CalDAG-GEFI (#3752, 1:5,000, dilution) (Crittenden
et al., 2004), c-Fos (Santa Cruz, sc-52, 1:10,000 dilution), or
vesicular acetylcholine transferase (VAChT) (Millipore, AB1588,
1:100) followed by the appropriate secondary antisera coupled
to ALEXA fluorophores (ThermoFisher Scientific, 1:300).
Following secondary incubation, sections were rinsed in 0.1
M PBS, mounted on subbed glass slides and coverslipped with
ProLong antifade reagent (Thermo Fisher Scientific). Imaging
was performed with a Zeiss LSM 510 confocal microscope with
Zen Software and the data were processed and analyzed with Fiji
software (Schindelin et al., 2012).
Amphetamine Treatments and Behavioral
Tests
Mice were injected at ∼10 am in their home cage for 3
days with saline only (10 ml/kg/day, i.p.) followed by 7 daily
injections of D-amphetamine (Sigma-Aldrich) dissolved in saline
(7 mg/kg/day, 10 ml/kg, i.p.), or saline vehicle, followed by 7 days
without treatment and then a final challenge with amphetamine
(7 mg/kg) or saline. To measure behavior on challenge day, the
bedding (nestlet) was removed from the cages of the test mice,
themice received their challenge injection of D-amphetamine (or
saline for the control mice) and, 30 min later, a ball of bedding
was introduced from a mixture from 10 cages of female mice.
Saline-treated mice were challenged again with saline 7 days later
and the same test was done, but with bedding re-introduced
from their own home cage. Mice were videotaped and their
behavior was scored for a 2 min period beginning at 5 min after
the introduction of the cage bedding. An experimenter blinded
to mouse treatment scored the videotapes using a keyboard
scoring system with the public domain software JWatcherTM,
version 1.0 (University of California, Los Angeles, CA, USA, and
Macquarie University, Sidney, Australia, http://www.jwatcher.
ucla.edu/). Individual keys were assigned to score resting,
locomotion, sniffing or touching bedding, and highly confined
stereotypy. The interaction of saline-treated mice with female
cage bedding vs. their own home cage bedding was compared
by a paired-sample, 2-tailed Student’s t-tests. The interaction of
amphetamine-treated mice vs. saline-treated mice with female
cage bedding was compared by an unpaired, 2-tailed Student’s t-
test. Statistical analysis of amphetamine-induced stereotypy and
interaction with female bedding was made on mice that carry the
ChAT-Cre transgene alone, but equivalent severe stereotypy was
observed in all double transgenic CalDAG-GEFI-GFP;ChAT-Cre
knock-in mice that were used for recording and c-Fos induction
experiments.
Intrastriatal Viral Injections
ChAT-IRES-Cre mice or double transgenic, CalDAG-GEFI-
EGFP-BAC;ChAT-IRES-Cre mice and CalDAG-GEFI-EGFP-
BAC;ChAT-ChR2-EYFP BAC mice were maintained in deep
anesthesia with a continuous flow of 2% isoflurane (Southmedic
Inc.) in an oxygen mixture, delivered by a nose-cone attached to
a stereotaxic frame. Mice were given bilateral intrastriatal
injections, via NanoFil microsyringe (World Precision
Instruments), of AAV5 encoding EF1αDIO hChR2(H134R)-
mCherry (University of N. Carolina vector core), 0.75µl per site,
at the following stereotactic coordinates (AP = 0.9mm, ML =
−1.9mm and +1.9mm, DV = 2.0 mm and 2.7 mm, relative
to bregma). Mice were allowed to fully recover from surgery
for 2 weeks prior to the initiation of saline or D-amphetamine
injections.
In vitro Slice Preparation and Patch-Clamp
Electrophysiology Recordings
For patch-clamp recording experiments, double transgenic
CalDAG-GEFI-GFP BAC;ChAT-Cre knock-in mice and
CalDAG-GEFI-GFP BAC;ChAT-ChR2-EYFP BAC mice were
given saline or drug treatments beginning at ∼2 weeks after
intrastriatal viral injection. At 30 min post-injection of saline
or drug on the challenge day, mice were anesthetized with
Avertin (tribromoethanol) (0.25 mg/g, i.p.), and brain slices
were prepared for whole-cell patch-clamp recordings. Slice
preparation and recordings were made by an experimenter
blinded to the treatment conditions. Mice (2–6 months old) were
anesthetized with Avertin (tribromoethanol, 0.25 mg/g, i.p.), and
the brains were rapidly removed and immersed in an ice-cold
(4◦C) slicing solution containing (in mM): 105mM N-methyl-
D-glucamine (NMDG), 105 mM HCl, 2.5 mM KCl, 1.2 mM
NaH2PO4, 26mM NaHCO3, 25mM glucose, 2mM thiourea, 1
mM Na-ascorbate, 3mM Na-pyruvate, 0.5 mM CaCl2·4H2O,
and 10 mM MgSO4·7H2O. The pH of the solution was titrated
to 7.4 with concentrated HCl equilibrated with 95% O2 and 5%
CO2, pH 7.4. Coronal corticostriatal slices (270µm) were cut
with a Leica VT1200 microtome. The slices were incubated,
initially in the above slicing solution, for 10 min at 32◦C, then
for 40 min and subsequently at room temperature in artificial
cerebrospinal fluid (ACSF) containing (in mM): 124mM NaCl,
2.5 mM KCl, 1.2 mM NaH2PO4, 26 mM NaHCO3, 10 mM
glucose, 2 mM CaCl2 · 4H2O, 1 mMMgSO4 · 7H2O, equilibrated
with 95% O2 and 5% CO2, pH 7.4. The osmolality of all solutions
was measured at 300–310 mOsm. Brain slices were transferred
from the incubation chamber to the recording chamber and
superfused with warmed (32◦C), equilibrated (95% O2 and 5%
CO2) ACSF at a flow rate of 2 ml/min. Whole-cell recordings
were obtained from visually identified dorsolateral striatal
neurons with an Olympus BX-51WI microscope (Olympus,
Japan) equipped with Nomarski optics, infrared differential
interference contrast (DIC) optics (900 nm) and epifluorescence.
Whole-cell patch-clamp recordings were obtained from visually
identified neurons using borosilicate glass pipettes (King
Precision Glass, Inc., Glass type 8250) pulled (P-1000, Sutter
Instruments) to a resistance of 2–5 M when filled with the
internal solution containing 131 mM K-Gluconate, 17.5 mM
KCl, 9 mM NaCl, 10 mM HEPES, 1 mM EGTA, 1 mM Mg-ATP,
0.2 mM Na2-GTP, and 1 mM MgCl2. The pH was adjusted to
7.3 with KOH (290–300 mOsm). In all recording conditions,
access resistance was monitored and cells were included for
analysis only if the series resistance was<25 M and the change
of resistance was <15% over the course of the experiment. A
Digidata 1440A digitizer and pClamp10 (Molecular Devices)
were used for data acquisition and analysis, and signals were
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amplified with aMulticlamp 700B amplifier (Molecular Devices).
A holding command of −70 mV was applied to the patched
cell, and once the whole-cell mode was established, the cell
was allowed to stabilize for 5–10 min. Both SPNs and ChIs
were identified by cell-body size and shape and by intrinsic
membrane properties. In current-clamp mode, light application
evoked depolarization and action potentials in identified
mCherry-positive ChIs in all except for one drug-treated,
CalDAG-GEFI-GFP BAC;ChAT-Cre knock-in mouse that was
therefore dropped from the study. In the single transgenic,
virally injected ChAT-Cre knock-in mice and double transgenic
CalDAG-GEFI-GFP BAC;ChAT-Cre knock-in mice, a blue
LED pulse (10 ms) was used to stimulate ChIs. In the double
BAC transgenic CalDAG-GEFI-GFP;ChAT-ChR2-EYFP mice,
a hand-controlled shutter was briefly opened to activate the
ChIs. For analysis of action potentials in SPNs, each SPN was
maintained at resting membrane potential and injected for 800
ms with depolarization currents of 20–200 pA (enough current
injection for adequate action potential firing). After a rest of 30
s, the same current sweep was repeated, this time with blue light
application at 500 ms after the beginning of current injection.
After 1 min of rest, another such pair of no-light/light current
sweeps was given but with a slightly higher current injection
to induce higher frequency firing. A total of 3 or 4 pairs of
no-light/light current sweeps were given to each cell.
In recordings from two CalDAG-GEFI-GFP BAC;ChAT-Cre
knock-in mice, and additional experiments with double BAC
transgenic CalDAG-GEFI-GFP;ChAT-ChR2-EYFP mice, DHβE
(1 mM; Tocris, Bristol, UK) was added to the perfusate after the
initial recordings and slices were allowed to equilibrate for 30min
before repetition of action potential measurements.
Electrophysiological Data Analyses
Data were obtained and recorded in ClampFit (Molecular
Devices), and the output abf files were converted in MiniAnalysis
(SynaptoSoft) to assign the timestamp of each spike. For spike
density functions, a 1 kHz sampling rate was used. The value
1 was assigned at each sample that corresponded to a spike
time, and the remaining samples were assigned the value 0. The
resulting time series was then smoothed with a Hanning window
whose half-width was 80 ms.
For the Grubbs’ test to identify outlier interspike intervals
(ISIs), trials of two sweeps (one without blue light pulse, one
with) were selected based on the following criteria: (1) the
combined pre-light baseline period contained at least 7 ISIs,
(2) the pre-light period contained at least two ISIs (no trial
failed this test after passing the first test), (3) the combined
pre-light baseline ISIs were normally distributed according to
the Lilliefors test with alpha = 0.001 (this low alpha value was
chosen because of the small sample sizes under examination),
and (4) the combined pre-light baseline ISIs did not contain
any outliers as determined by the Grubbs’ test. All but one
neuron had at least one analyzable trial, although in most cases
the first trials had too few spikes to analyze. The first ISI was
discarded because in some instances it appeared to be longer
than the remaining ones. To test for a significant “advanced
spike” response, the minimum ISI recorded during the post-light
period was added to the pre-light baseline set of ISIs, and the
Grubbs’ test for an outlier was performed. To test for a “pause”
response, the Grubbs’ test was performed again but with the
maximum post-light ISI added to the pre-light baseline set. If the
duration between the last spike of the trial and the termination
of current injection was longer than the longest recorded ISI,
it was used in place of the maximum ISI. As two Grubbs’ tests
were performed on each of 123 trials that met our criteria, we
used the Bonferroni correction for 246 comparisons to set alpha
= 0.0002, corresponding to a p level of 0.05 for the entire set of
comparisons.
The Lilliefors statistical test was performed using the Matlab
function “lillietest.” Other tests were performed by in-house code
written around the Matlab functions “chi2cdf” (Chi squared
tests) and “tinv” (Grubbs’ test).
RESULTS
Mice Engaged in Amphetamine-Induced
Repetitive Behaviors Fail to Respond
to a Sensory Cue and Exhibit
Striosome-Enriched c-Fos Induction
To test whether mice with drug-induced stereotypies fail to
respond to salient sensory cues, we measured the response
of single-housed, amphetamine-treated male mice to the
introduction of bedding from female cages to their own cage.
To induce stereotypy, mice were treated for 7 days with high-
dose D-amphetamine (7.0 mg/kg/day, i.p.), followed by 7 days
of no-treatment and then a challenge dose (7.0 mg/kg, i.p.), as
previously described (Figure 1A; Crittenden et al., 2014). Control
mice were treated in parallel with vehicle (saline) injections only.
On the challenge day, at 30 min after injection, we introduced a
ball of used bedding taken from multiple cages of females. We
scored the times the mice spent sniffing the bedding, locomoting
or engaging in confined stereotypic behaviors based on a video
taken 5 min after the introduction of the female bedding. Control
mice spent between 30 and 50% of the time sniffing the female
bedding (Figure 1B). We compared this level to the times that
they interacted with bedding that had been taken from their own
home cage and found that they spent significantly more time
interacting with the female cage bedding (Figure 1B), supporting
the interpretation that female cage bedding is a salient cue. By
contrast, mice that were treated with repeated amphetamine
spent most of their time engaging in stereotypic behaviors,
sometimes interrupted by running bouts, and did not interact
with the female cage bedding at all (Figure 1B).
To test whether the mice exhibiting drug-induced stereotypy
had imbalanced striosome-to-matrix ratios of immediate-early
gene activation, as occurs in rats and monkeys (Canales and
Graybiel, 2000; Saka et al., 2004; Horner et al., 2012; Jedynak
et al., 2012), we imaged c-Fos expression in striatal sections
taken from D-amphetamine-treated mice (n = 4) compared to
saline-treated mice (n = 4). To detect the striosome and matrix
compartments, we used BAC transgenic mice (Gong et al., 2007)
with an enhanced GFP reporter for the matrix-enriched signaling
molecule, CalDAG-GEFI (Kawasaki et al., 1998; Crittenden et al.,
2016). The compartmental selectivity of CalDAG-GEFI-GFP
expression followed gradients across the striatum, with the
Frontiers in Neuroanatomy | www.frontiersin.org 5 March 2017 | Volume 11 | Article 20
Crittenden et al. Cholinergic Interneurons Modulate Striosomal Activity
FIGURE 1 | Mice with amphetamine-induced stereotypy fail to engage
with a salient sensory cue. (A) Schedule of D-amphetamine or saline
injections. (B) Analysis of behavior in saline-treated (n = 8) or
D-amphetamine-treated mice (n = 8), for a 2 min videotaped interval at 30 min
after injection, and 5 min after the introduction of bedding from female cages,
or from their own home cage (for saline-treated only). The saline-treated mice
interacted more with the female cage bedding than with bedding that was
re-introduced from their own home cage (*p = 1.2 × 10−3, paired t-test).
D-amphetamine-treated mice did not spend any time sniffing the female
bedding (**p = 8.1 × 10−11, unpaired t-test, relative to saline-treated mice
with female bedding). Error bars show standard deviations.
compartmental borders being easiest to identify in the central
and lateral parts of the caudoputamen (Figures 2A–C). CalDAG-
GEFI-GFP mice were treated with D-amphetamine or saline,
according to the schedule shown in Figure 1A, and brain tissue
was taken for analysis 90 min after the challenge injection.
Mice that received amphetamine injections, but none of the
saline-treated mice, were engaged in stereotypic behaviors at
the time of euthanasia. Saline-treated control mice showed low
levels of c-Fos expression in cell nuclei distributed across both
compartments in the striatum (Figures 2D–F). By contrast, the
striatum of the D-amphetamine-treated mice showed strong
expression of c-Fos in the striosomes, with a lower density of
c-Fos-positive nuclei in the surrounding matrix compartment
(Figures 2G–I).
Cholinergic Interneurons of the Striatum
Project Their Axons into Both Striosome
and Matrix Compartments of Both Control
and Drug-Treated Mice
To allow simultaneous detection of striatal ChIs
and striosome-matrix compartments, we crossed the
CalDAG-GEFI-GFP BAC mice to ChAT-Cre knock-in mice
(Table 1). In the ChAT-Cre knock-in mice, Cre recombinase
is fused to the end of the choline acetyltransferase gene at
its endogenous locus (Rossi et al., 2011) so as not to evoke
over-expression of the nearby VAChT gene, as has been reported
to occur in ChAT BAC transgenic mice (Kolisnyk et al., 2013;
Crittenden et al., 2014). We labeled ChIs in the double transgenic
mice by intrastriatal injections of an AAV5 virus encoding a
Cre-dependent transgene for the mCherry fluorophore fused
to channelrhodopsin [Ef1αDIOhChR2(H134R)-mCherry]
(Mattis et al., 2012). The infected mCherry-positive cells
(Figures 3A–F) resembled ChIs in that they were large and
appeared scattered across the striatum, contained substantial
extra-nuclear cytoplasm in the soma, and had multiple spots
in the nucleus that stained for the chromatin-marker DAPI
(Matamales et al., 2009). We confirmed that these mCherry-
positive neurons expressed the endogenous cholinergic cell
marker VAChT in their cell bodies (in cyan in Figures 3G,H).
Very fine ChI fibers, presumably axons, were present in both
the striosomes and matrix (Figure 3F). Thicker, presumably
dendritic, processes were concentrated in the matrix, with some
running along compartment borders and occasionally crossing
the borders (Figure 3F).
To be sure that the ChI innervation of both striosomes and
matrix wasmaintained after repeatedD-amphetamine treatment,
we injected the double transgenic mice intrastriatally with the
AAV5-ChR2-mCherry, waited for 2 weeks, and then treated the
mice with D-amphetamine according to the standard schedule
(Figure 1A) prior to collection of brain tissue on the challenge
day. As in control mice, cholinergic neurons were evident along
with dense neuropil from infected ChIs (Figures 3I–M).
Cholinergic neuropil, though present in both compartments,
was not homogenously distributed across the striatum, in accord
with previous findings (Graybiel et al., 1986). The cholinergic
neuropil distribution wasmost clearly evident inmice with global
labeling for cholinergic cell reporters (double transgenic knock-
in ChAT-Cre;Ai32-EYFP mice and single BAC transgenic ChAT-
ChR2-EYFP mice, (Table 1; Figure 4). Striosomes, especially in
the medial striatum, were often visible as darker regions with
reduced densities of large cholinergic processes, both in the
ChAT-Cre mice with intrastriatal viral injections and in the
ChAT-Cre;Ai32-EYFP knock-in and ChAT-ChR2-EYFP BAC
mice.
Cholinergic Interneuron Activation Induces
a Pause or a Spike Advance to Disrupt SPN
Firing Patterns
We made whole-cell patch-clamp recordings from GFP-positive
striatal neurons in the matrix and from GFP-negative striatal
neurons within striosomes of CalDAG-GEFI-GFP BAC mice
(Figures 5A–F). With the goal of testing for cholinergic
modulation of excitatory inputs to SPNs, we measured the
amount of current injection required to induce repetitive spiking
activity (rheobase) in striosomal and matrix SPNs. SPNs typically
fired regularly at current injection levels above rheobase, and
striosomal neurons were more excitable than matrix neurons in
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FIGURE 2 | Induction of c-Fos expression is striosome-predominant in D-amphetamine-treated mice. (A–C) Image of GFP fluorescence in a coronal
hemisection through the left striatum of a CalDAG-GEFI-GFP BAC transgenic mouse used to differentiate striosomes and matrix (A) and co-immunolabeling for the
striosome marker, MOR1 (B), with merged image (C). (D–I) Sections from transgenic mice treated with repeated saline (D–F) or repeated D-amphetamine (G–I)
showing CalDAG-GEFI-GFP fluorescence (D,G) and c-Fos co-immunolabeling (red nuclei) (E,H). Merged images (F,I) illustrate the striosome-predominant c-Fos
induction by the D-amphetamine challenge injection. Asterisks indicate examples of striosomes. Similar results were observed in 4 saline-treated and 4
D-amphetamine-treated mice.
the striatal slices taken from mature mice (n = 33 striosomal
SPNs, n = 32 matrix SPNs, from 16 mice; Figures 5G–I), as
previously reported for slices taken from young mice and rats
(Kawaguchi et al., 1989; Miura et al., 2007; Smith et al., 2016).
As a direct test of whether the striatal ChIs can modulate
activity in striosomal and matrix SPNs, we then made whole-cell
patch-clamp recordings in coronal slices through the striatum of
double transgenic CalDAG-GEFI-GFP BAC;ChAT-Cre knock-in
mice in which intrastriatal injections of AAV5-ChR2-mCherry
had been made (Figures 3A–F, 6A). At 2 weeks after intrastriatal
virus injection, the double transgenic CalDAG-GEFI-GFP
BAC;ChAT-Cre knock-in mice began daily saline injections in
order that they could serve as controls for comparison to sibling
mice treated with D-amphetamine (Figure 1A). After the final
injection, we prepared brain slices and applied wide-field, 10ms
blue light pulses to the striatal slices (Figure 6A). This treatment
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FIGURE 3 | Cholinergic interneuron processes in striosomes and matrix of control and D-amphetamine-treated mice. Striatal sections from
CalDAG-GEFI-GFP BAC;ChAT-Cre knock-in mice labeled for GFP in the matrix (A,D,I,K), AAV5 Cre-dependent ChR2-mCherry in ChIs (B,E,J,L), and merged images
from double transgenic mice (C,F,M) treated with saline (A–F) or repeated D-amphetamine (I–M). Immunofluorescence (cyan) for VAChT (G) confirms the cholinergic
identity of an AAV-infected mCherry-positive neuron (H). Asterisks indicate examples of striosomes.
reliably generated an action potential in ChIs of both saline-
treated and amphetamine-treated mice (Figure 7A). To test how
ChI activation modulated SPN activity, we induced epochs of
regular SPN spiking activity by 800 ms current injection sweeps.
We then compared SPN responses to current injection alone to
the responses elicited 30 s later by the same current injection
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FIGURE 4 | Cholinergic neuropil is not homogenously distributed across the striatum. Hemi-sections through the left striatum from ChAT-Cre;Ai32-EYFP
knock-in (A–C) and ChAT-ChR2-EYFP BAC (D–F) transgenic mice showing fluorescence labeling of global cholinergic neuropil in green (A,D) relative to
co-immunolabeling in red for the matrix marker CalDAG-GEFI (B) or striosome marker MOR1 (E). (C,F) Merged images. Asterisks indicate examples of striosomes.
combined with a 10 ms light pulse beginning at 500 ms after
the start of current injection (Figure 6B). Most neurons in the
control group exhibited a pause or marked reduction in spiking
following the light pulse, and some also showed a single spike
at short latency after light application, typically followed by a
pause (Figures 6B,C; n = 5 ChAT-Cre knock-in mice with viral
expression of ChR2, 35 striatal neurons, 12 from striosomes, 10
frommatrix, and 13 frommice with no matrix-GFP label). These
effects were found in both single transgenic ChAT-Cre knock-in
mice and double transgenic CalDAG-GEFI-GFP BAC;ChAT-Cre
knock-inmice (Figure 6C). To insure that the responses were not
artifacts of light application, we measured the SPN responses in
single transgenic CalDAG-GEFI-GFP BAC mice with no ChR2
expression. In these control mice, the light application did not
disrupt firing at all (data not shown).
Responses of a given SPN to the ChI activation were generally
consistent across different trials at different current intensities,
as shown in Figures 8A–C. SPNs typically exhibited one of
three response types: advanced spike followed by a pause, pause
only (without advanced spike), and non-responsive. The pause
response was observed more frequently than the advanced spike
response, but there was one exceptional neuron that responded
to the light with advanced spikes but no pause (Table 2). In
neurons with advanced spikes, the extra spikes were limited
to a time window of about 40 or 50 ms after light onset
(Figure 8D). To quantify these differences, we developed a
statistical analysis to detect both increases and decreases in firing
rate on a trial-by-trial basis. For each trial, ISIs were calculated
for spikes in three time windows (Figure 6C): the first current
injection (“baseline”), the portion of the second current injection
preceding the light (“pre-light”), and the remainder of the second
current injection (“post-light”). We then used Grubbs’ test (see
Materials and Methods) for outliers to determine whether the
shortest and/or the longest post-light ISIs could be considered
outliers in the context of the pre-light baseline ISIs. By this
method, we found that both the pause and the advanced spike
responses (Table 2) were statistically significant.
Striosomal SPNs Can Be More Responsive
to ChI Modulation than Matrix SPNs
To calculate the statistical significance of the striosomal and
matrix SPN responses to light, we compared the total numbers
of spikes in the response period from 40 to 150 ms after light
onset to the numbers of spikes in the baseline and pre-light time
windows (Figure 6C). We added the spike counts in the baseline
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FIGURE 5 | Increased excitability in striosomal SPNs. (A–F) Photomicrograph of the left dorsolateral striatum from a CalDAG-GEFI-GFP BAC transgenic mouse
with transmitted light (differential interference contrast) (A–C) and epifluorescence (D–F) microscopy. Green asterisk denotes matrix, and white denotes a striosome
in (D). Patch-clamp recording pipette in contact with a GFP-positive matrix cell (B,E) or a striosomal cell (C,F). Black and white arrows point to cell somata patched
with a recording pipette. (G,H) Current-voltage curve traces from a matrix SPN with rheobase (320 pA) in dark green (G) and a striosomal SPN with rheobase (140 pA)
in magenta (H). (I) Striosomal SPNs (magenta) are more excitable than matrix SPNs (green) as measured by resting membrane potential, current injection for
rheobase, spike-firing frequency at rheobase, IV curve, and membrane time constant. ***p < 0.0005 by Mann-Whitney Rank Sum test.
and pre-light windows, and then performed a chi-squared test
with Yates’ correction comparing the actual spike counts in the
response window and combined pre-light baseline window with
the values expected under the null hypothesis that the light
had no effect. The entire procedure was repeated separately for
identified striosomal SPNs and identified matrix SPNs (Table 3).
Striosomal SPNs as a group showed a significant effect of the
light at a substantially lower p level than did the matrix group
(p = 1.2 × 10−7 vs. p = 0.009). To verify that this difference
reflected a stronger response to the light in striosomal SPNs,
we performed a chi-squared test for dependence between the
effects of neuron type (striosomal vs. matrix) and time window
(pre-light baseline vs. response). The null hypothesis of no
difference between striosomal and matrix SPNs was rejected
with a significance level of p = 0.016 for the slice recordings
from saline-treated mice. When aggregating spike counts across
different neurons, the results will be dominated by the highest
firing neurons. There were 3 out of 22 compartment-identified
SPNs in the saline-treated group and 1 out of 14 compartment-
identified SPNs in the amphetamine-treated group that had spike
counts during the combined pre-light baseline window that were
more than 1.5 times the aggregated median value. We repeated
the statistical analysis after excluding these neurons (Table 4) and
found with a chi-squared test that the group of striosomal SPNs
still showed a trend to be more significantly affected than the
matrix SPNs, but now with a non-significant p = 0.14. Just as
before the exclusion of the more highly firing neurons, both the
striosomal and matrix SPNs were found to be responsive to ChI-
mediated modulation (p= 9× 10−5 for striosomal vs. p= 0.024
for matrix SPNs).
Firing Activity of Striosomal and Matrix
SPNs Is Resistant to ChI-Mediated
Disruption in Mice with Drug-Induced
Stereotypy
To test whether SPNs from mice in a state of severe repetitive
behavior exhibit abnormalities in the ChI-to-SPN signaling
microcircuit, we recorded in slices taken from mice engaged
in amphetamine-induced stereotypy (n = 4 ChAT-Cre knock-
in mice with viral expression of ChR2, 24 striatal neurons,
7 from striosomes, 7 from matrix, and 10 from mice with
no matrix-GFP label). On the amphetamine challenge day,
we isolated brain tissue at the 30 min time-point after
D-amphetamine injection and prepared striatal sections for
whole-cell recording (Figure 1A). The drug-treated mice were
confirmed to be in a state of stereotypy at the time of
tissue collection. ChIs in the dorsal striatum of slices from
the drug-treated mice responded reliably to light stimulation
(Figure 7B) except in one mouse; data from this mouse
were not included in the analyses. We did not analyze
baseline activity of ChI activity in control or drug-treated
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FIGURE 6 | ChI activation disrupts spiking pattern in striosomal and matrix SPNs, but not after D-amphetamine treatment. (A) Cartoon of slice recording
set-up with ChI (yellow), matrix SPN (green) and striosomal SPN (magenta) in a mouse with CalDAG-GEFI-GFP labeling in the matrix and blue light responsive ChR2 in
the ChIs. (B) A timeline showing the schedule of paired 800 ms current injections used, with light pulse during the second sweep. Examples of a pause (top trace) and
a spike advance followed by a pause (bottom trace) after optogenetic activation of ChIs (at blue line). (C,D) Raster plots (upper) and spike density functions (lower) of
all of the spikes recorded across all sweeps (one trial per row) from saline-treated (C) and D-amphetamine-treated (D) mice. In the raster plots, matrix SPN spikes are
in green, striosomal SPN spikes in magenta and compartmentally unidentified SPN spikes from single transgenic ChAT-Cre knock-in mice in black. Spike density
functions are averaged over all trials from identified matrix (green) and striosomal (magenta) SPNs. The blue line indicates the onset of 10 ms light stimulus. Gray
shading denotes the “baseline” period (270–800 ms after the start of the first current injection) and the “pre-light” period (from 270 ms after the start of the second
current injection until light onset). Yellow shading denotes the “response” period (from 40 to 150 ms after light onset).
mice but, rather, tested whether SPNs responded differently
to the single spike induced by optogenetic stimulation of the
ChIs.
The raster plots and spike density plots of the striosomal
and matrix SPN responses to ChI stimulation showed a severely
blunted SPN response in the slices from D-amphetamine-
treated mice (Figure 6D). We evaluated the significance of the
responses by performing chi-squared tests with Yates’ correction
to compare the spike counts in the post-light time-window and
the baseline plus pre-light spike counts with the values expected
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FIGURE 7 | ChI spike responses to blue-light stimulation. Black traces
show that ChIs, expressing ChR2-mCherry from AAV5 injections, fired single
action potentials in response to 10 ms blue light pulses (vertical blue lines) in
striatal slices from saline-treated (A) and D-amphetamine-treated (B)
CalDAG-GEFI-GFP BAC;ChAT-Cre knock-in mice.
under the null hypothesis that the light had no effect. These tests
showed that neither striosomal nor matrix SPN firing frequencies
showed a significant response to the light (p = 0.4 for striosomal
SPNs and p = 0.4 for matrix SPNs). We performed a chi-
squared test for dependence between the effects of neuron type
(striosomal vs. matrix) and time window (pre-light baseline vs.
response) and found that no difference was apparent (p = 0.9).
Although there were some neurons that showed a response to
the light after D-amphetamine treatment (Table 5; Figure 8E),
the proportion of SPNs that responded was much lower in the
drug-treated group (Figure 8F) than in the saline-treated group
(22% vs. 74% respectively), and this difference was significant by
Fisher’s exact test (p= 1.3× 10−4).
To confirm that our results were not unique to virally
mediated expression of ChR2, we also made recordings in
double BAC transgenic CalDAG-GEFI-GFP;ChAT-ChR2-EYFP
mice that had global cholinergic expression of a ChR2 transgene
(n = 5 mice) and that were treated with either repeated saline
or repeated D-amphetamine (Figure 1A). For these tests, we
administered blue light with a manually controlled shutter, thus
inducing multiple spikes in the ChIs of saline-treated and D-
amphetamine-treated mice (Figures 9A,B). We recorded from 7
SPNs that were CalDAG-GEFI-GFP-positive (matrix) and 7 SPNs
that were in CalDAG-GEFI-GFP-negative zones (striosomes).
In the saline-treated preparations, we observed that the spiking
pattern of both striosomal and matrix SPNs could be disrupted
by a pause or by a spike advance (Figures 9C–F), as we had
found for the SPN responses in ChAT-Cre knock-in mice with
virally expressed ChR2. However, in slices taken from the
amphetamine-treated mice expressing severe D-amphetamine-
induced stereotypy (n = 5 mice, 29 striatal SPNs, 13 from
striosomes, 16 from matrix), the striosomal and matrix SPNs no
longer responded to light (Figures 9G,H). Thus, ChI activation
normally produced a pause or spike-advance in the regular firing
pattern of striosomal and matrix SPNs in brain slices from two
different lines of transgenic mice but these effects were blocked
in slices taken from amphetamine-treated mice exhibiting drug-
induced stereotypic behavior.
D-Amphetamine Treatment Did Not Induce
a Chronic, Baseline Failure in the Ability of
ChIs to Disrupt SPN Firing Patterns
Repeated methamphetamine treatments can produce prolonged
changes in baseline striatal acetylcholine signaling (Bamford
et al., 2008). To test whether the ChI to SPN signaling phenotype
that we observed in drug-treated mice was due to a baseline
change in SPN responsivity, we treated mice with the same 7-
day drug treatment schedule but challenged them with saline,
not amphetamine, prior to recording (n = 2 mice, 10 striatal
neurons, 3 from striosomes, 3 from matrix, and 4 from mice
with no matrix-GFP label). As before, we harvested brain slices
at 30 min after the challenge, and we confirmed, in every slice,
that ChIs responded to the 10 ms light pulse with a spike.
Optogenetic stimulation of ChIs in striatal slices taken from
these mice appeared to disrupt SPN spike-timing just as in
mice that had never been exposed to drug (Figure 10). A chi-
squared test comparing spike density in the baseline and pre-light
periods to the period after light application (periods highlighted
in Figure 10) showed that there was a significant effect in each
mouse that was tested (p= 0.0013 and p= 4.2× 10−5), and when
the results from both mice were combined, the value was p= 4.6
× 10−7.
The Disruption of Striosomal and Matrix
SPN Firing Pattern by ChI Activation Is
Dependent on Nicotinic Acetylcholine
Receptors
ChI signaling can drive disynaptic inhibition in SPNs by
activating nicotinic receptors on nearby terminals (Miura et al.,
2006; English et al., 2012; Tritsch et al., 2012; Luo et al., 2013;
Nelson et al., 2014b; Faust et al., 2015). We tested whether bath
application of the α4β2 nicotinic receptor antagonist, DHβE,
would block the response to ChI stimulation that we found
in striosomal and matrix SPNs. We recorded from 4 SPNs in
the CalDAG-GEFI-GFP-negative (striosomes) and 2 CalDAG-
GEFI-GFP-positive (matrix) SPNs, all of which responded with
a pause or a spike-advance to the optogenetic stimulation of
ChIs (examples shown in Figures 11A,B, left panels). After bath
application of DHβE, these same 6 SPNs no longer responded
to the light (Figures 11A,B, right panels). Similarly, in ChAT-
ChR2-EYFP BAC mice, bath-applied DHβE blocked the light-
induced responses of 8/10 SPNs (Figure 11C).
DISCUSSION
ChIs Send Abundant Axonal Projections
into Striosomes and Matrix Circuits
Implicated in Selecting Behavioral
Responses to Salient Cues
Stereotypy can be viewed as an extreme loss of behavioral
flexibility (Graybiel, 2008) and loss of responsiveness to salient
cues, a feature recognized in individuals with disorders on
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FIGURE 8 | ChI activation induces a pause or a spike that disrupts SPN spike-timing patterns. Raster plots (top) and trial-averaged spike density functions
(bottom) grouped according to neuronal response type. SPN types are color coded as in Figure 6. To show which trials belong to an individual SPN, spikes from
odd-numbered neurons within each color group are plotted as plus signs, and those from even-numbered as diamonds (one trial per row). (A–C) SPNs recorded in
saline-treated mice, showing advanced spike response (A), pause response (B) or no response (C). (D) Expanded time scale showing SPNs with advanced spike
response in saline-treated mice. (E,F) SPNs recorded in D-amphetamine-treated mice, showing pause response in 4 neurons (E) or no response (F).
the autism spectrum (Gotham et al., 2007). Presentation of an
instructive cue induces a semi-synchronized response in striatal
ChIs consisting of a brief activation followed by a pause in spiking
and then a rebound activation before a return to unsynchronized,
tonic firing (Aosaki et al., 1994b; Minamimoto and Kimura,
2002; Goldberg and Reynolds, 2011; Doig et al., 2014; Thorn and
Graybiel, 2014). A leading hypothesis is that this ChI response
is important for an animal’s ability to adapt its behavior in
accordance with predicted outcomes (Minamimoto et al., 2005;
McCool et al., 2008; Brown et al., 2010; Ding et al., 2010;
Goldberg and Reynolds, 2011; Okada et al., 2014). The response
of ChIs to cue presentation is dependent upon inputs from the
sensory thalamus, the dopaminergic system and the cerebral
cortex (Aosaki et al., 1994a; Goldberg and Reynolds, 2011; Doig
et al., 2014). Inputs from sensory thalamus to ChI dendrites
are matrix-preferring (Fujiyama et al., 2006; Raju et al., 2006).
Consistently, we observed that ChI dendrites appeared slightly
more prominent in the matrix compartment, relative to the high
abundance of ChI axons in both striosomes and matrix. Thus,
ChI dendrites, as well as labeling ofmatrix-preferring inputs from
brainstem cholinergic projections (Dautan et al., 2014), likely
account for the overall matrix-enriched expression of transgene
reporters, immunomarkers and chemical markers for cholinergic
processes (Graybiel et al., 1986; Crittenden et al., 2014).
Psychomotor stimulants are well known to induce stereotypic
behaviors, and in accordance with this linkage, we found that
after repeated high-dose D-amphetamine treatment, male mice
were engaged in stereotypy and failed to respond when we
introduced the normally salient stimulus of bedding taken from
female cages. Multiple brain regions and signaling mechanisms
are implicated in evoking stereotypic behaviors of different
sorts (Berridge, 2006; Mason and Rushen, 2008). In the dorsal
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TABLE 2 | Response types of neurons in saline-treated control mice.
35 analyzed neurons Matrix
(n = 10)
Striosomal
(n = 12)
Unidentified
(n = 13)
Pause 7 10 8
Advanced 1 0 7
Both 1 0 6
Neither 3 2 4
If a neuron showed a statistically significant pause response in at least one trial, then it
was counted as having a pause response, and similarly for advanced spike responses.
TABLE 3 | Chi-squared test results for effect of light on total spike count.
p Striosomal Matrix
Saline 1.2 × 10−7 0.009
Drug 0.30 0.32
TABLE 4 | Chi-squared test results for effect of light after excluding
high-firing neurons.
p Striosomal Matrix
Saline 9 × 10−5 0.024
Drug 0.30 0.44
TABLE 5 | Response types of SPNs in D-amphetamine-treated mice.
23 analyzed neurons Matrix
(n = 7)
Striosomal
(n = 7)
Unidentified
(n = 9)
Pause 1 2 2
Advanced 0 0 1
Both 0 0 1
Neither 6 5 7
striatum, dopaminergic and cholinergic signaling modulate
drug-induced stereotypic behaviors (Capper-Loup et al., 2002;
Aliane et al., 2011; Crittenden andGraybiel, 2016). Both increases
and decreases in acetylcholine signaling have been implicated
in the induction of stereotypic behavior, highlighting how a
balance of neurotransmitter effects may be what is key to
preventing this pathological behavior. For example, the ablation
or inhibition of ChI signaling in the striosome-rich anteromedial
dorsal striatum prolongs cocaine-induced stereotypy in rats
(Aliane et al., 2011), but as well, mice with abnormally high
levels of VAChT, thought to augment acetylcholine release,
exhibit increased amphetamine-induced stereotypy (Crittenden
et al., 2014). Stimulation of the ionotropic nicotinic receptors
increases motoric responses to cocaine and amphetamine
(Schoffelmeer et al., 2002; Collins and Izenwasser, 2004), whereas
antagonism of the slower metabotropic muscarinic signaling
system generally increases cocaine-induced responses, including
stereotypy (Thomsen et al., 2010; Aliane et al., 2011). Thus,
the relationship between cholinergic signaling and stereotypy is
FIGURE 9 | ChI activation disrupts spiking patterns in striosomal and
matrix SPNs by a pause or an advanced spike in ChAT-ChR2-EYFP
BAC mice and the effect is blocked by D-amphetamine treatment.
(A,B) ChIs showed a burst of firing in response to shutter-controlled blue light
application (designated by horizontal blue lines) in striatal sections from
saline-treated (A) and D-amphetamine-treated (B) ChAT-ChR2-EYFP BAC
mice. (C–F) Current-induced spiking in striosomal (magenta, C,E) and matrix
(green, D,F) SPNs is disrupted by an advanced spike (C,D) or a pause (E,F)
after blue-light application. (G,H) The striosomal (magenta, G) and matrix
(green, H) SPN responses to ChI activation with blue light is blocked in
sections from D-amphetamine-treated mice.
complex, with contradictory observations being reported. Some
ideas that may help reconcile them are (1) muscarinic and
nicotinic transmission may in general have opposite effects,
(2) disrupting cholinergic transmission in different districts
of the striatum has different effects, and so (3) stereotypies
may be controlled both by stimulation and by inhibition of
cholinergic transmission, depending on exactly where and how
the stimulation or inhibition is accomplished. How this relates to
the role of acetylcholine in cue-detection remains unknown.
Drugs of Abuse and Imbalanced Striosome
vs. Matrix Gene Activation
With repeated administration of psychomotor stimulants, overall
gene induction in the matrix of the dorsal striatum is suppressed
relative to control treatments (Steiner and Gerfen, 1995; Nguyen
et al., 2009), and the striosome-to-matrix ratio of c-Fos
immediate-early gene induction is increased (Graybiel et al.,
1990; Canales and Graybiel, 2000; Vanderschuren et al., 2002;
Saka et al., 2004; Jedynak et al., 2012). By contrast, rats engaged in
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FIGURE 10 | Striosomal and matrix SPN responses to ChI activation
were maintained in mice that received repeated D-amphetamine
treatment but were challenged with saline only. Raster plots (upper) and
spike density functions (lower) of all of the spikes recorded across all sweeps
(one trial per row). In the raster plots, matrix SPN spikes are in green,
striosomal SPN spikes in magenta and compartmentally unidentified SPN
spikes from single transgenic ChAT-Cre knock-in mice in black. To show which
trials belong to an individual SPN, spikes from odd-numbered neurons are
plotted as plus signs, and those from even-numbered as diamonds. Spike
density functions are averaged over all trials from identified matrix (green) and
striosomal (magenta) SPNs. The blue line indicates the onset of 10 ms light
stimulus. Gray shading denotes the “baseline” and “pre-light” periods and
yellow shading denotes the “response” period.
normal behaviors in their home cage are reported to have similar
levels of metabolic activity in the two compartments (Brown
et al., 2002). Experiments aimed at directly ablating striosomes in
rats by intrastriatal injection of MOR1-binding toxins (Tokuno
et al., 2002; Lawhorn et al., 2009) have been reported to
result in reduced stereotypic responses to methamphetamine
and increased c-Fos induction in the matrix (Murray et al.,
FIGURE 11 | Nicotinic acetylcholine antagonism blocks the ChI
disruption of SPN spiking activity. (A,B) Current-induced spiking in
striosomal (A) and matrix (B) SPNs from CalDAG-GEFI-GFP BAC;ChAT-Cre
knock-in mice is disrupted by blue light pulse (left traces) but the effect is
blocked after application of DHβE (right traces). (C) Spiking in two SPNs from
ChAT-ChR2-EYFP BAC mice that showed an advanced spike or pause
response (left traces) that was blocked after application of DHβE (right traces).
2014). Our experimental mice showed the expected imbalance in
striosome-to-matrix c-Fos induction after a challenge injection
of D-amphetamine, with strong nuclear c-Fos immunoreactivity
in neurons of GFP-negative striosomes and low levels of c-Fos
in neurons of the surrounding matrix. The saline-treated mice
showed low-level c-Fos immunostaining that was similar across
the compartments. The predominant striosomal activity in drug-
treated animals, as measured by the proxy of c-Fos induction,
could serve to minimize excess dopamine release driven by drugs
of abuse. This speculation would fit with a bare-bones circuit
model whereby relative activation of striosomal SPNs directly
inhibits dopamine-containing neurons in the substantia nigra
pars compacta, and relative silencing of matrix SPNs disinhibits
substantia nigra reticulata neurons that thereby are released to
inhibit the dopamine-containing neurons.
ChI Modulation of SPN Spike Firing
Patterns in Striosomal and Matrix SPNs
The electrophysiological response of SPNs to direct ChI
stimulation has been previously described without classification
of striosomal or matrix cell type and thus should favor those
in the matrix, which makes up most of the total volume of
the striatum. Analyses of SPN responses to ChI stimulation
have shown that there are multiple inhibitory post-synaptic
currents with fast, slow and very slow time-courses (English
et al., 2012), and small excitatory post-synaptic currents (Higley
et al., 2011). The inhibitory effects can be transmitted from
ChIs to SPNs disynaptically, via nicotinic receptor-mediated
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release of GABA from neurogliaform and tyrosine hydroxylase-
positive striatal interneurons (English et al., 2012; Luo et al.,
2013; Faust et al., 2016), from other SPNs (Miura et al., 2006), or
from dopamine-containing afferents (Tritsch et al., 2012; Nelson
et al., 2014b). Acetylcholine can also inhibit SPNs via muscarinic
receptors on SPNs (Clements et al., 2013) and via muscarinic
receptor-mediated suppression of glutamate release from cortical
terminals (Ding et al., 2010). The effects of ChI activation on
striatal microcircuits can be particularly powerful, at least as
measured in slice preparations, in that single spikes of ChIs
can promote nicotinic receptor-mediated release of GABA and
recurrent inhibition (Sullivan et al., 2008; Inoue et al., 2016). The
findings raise the possibility that the prominent pause in tonic
ChI activity might in fact be preceded by a single, instructive
ChI action potential. We found that optogenetic induction of a
single spike in ChIs in striatal slices could induce both a brief
pause of evoked firing activity and a spike advance in striatal
SPNs. Prolonged ChI stimulation appeared to have the same brief
consequence on SPN firing patterns.
Relative to SPNs in the matrix, we found that striosomal SPNs
showed a greater response to ChI stimulation. Considering the
diversity of SPN cell types (Gokce et al., 2016), a larger sample of
neurons would make this conclusion firmer. We found that the
SPN responses to ChI activation were blocked by bath application
of the β2 nicotinic receptor antagonist, DhβE, consistent with
a disynaptic inhibition microcircuit, such as that relayed by
nicotinic acetylcholine receptors on GABAergic terminals. All
together, these results suggest that there may be greater nicotinic
receptor-dependent transmission from GABAergic terminals
onto at least some striosomal SPNs than onto matrix SPNs.
We and others previously found that subsets of nigral neurons
(Gerfen et al., 1987; Jimenez-Castellanos and Graybiel, 1987;
Prensa and Parent, 2001; Crittenden et al., 2016), which from
their positions are likely overlapping with those that synthesize
GABA (Kim et al., 2015), appeared to project more abundantly
to striosomes than to the matrix. Thus, striosome-enriched
terminals from GABAergic dopamine-containing neurons are
one potential source of the increased ChI-mediated inhibition of
striosomal neurons.
Friedman and colleagues found that relatively selective
activation of striosomal SPNs, induced by optogenetic
manipulation of prelimbic cortex input fibers, biased rats’
cost-benefit trade-off decisions in a T-maze task, so that rats
were biased to choose the high-cost/high-value arm over the
low-cost/low-value arm (Friedman et al., 2015). This effect
appeared to be mediated by a microcircuit in which the activity
of high-firing inhibitory interneurons of the striatum was
normally enhanced by prelimbic cortical inputs during the
trade-off task, leading to suppression of putative striosomal
prelimbic-recipient SPNs, but not of non-prelimbic-recipient
SPNs of the extrastriosomal matrix. Our results here suggest
that other microcircuits, involving ChIs, could be important
for the relative inhibition, or disruption of spike timing,
in striosomes. It is clearly of great interest that these two
classes of striatal interneurons both appear to affect SPN spike
timing, a fundamental characteristic of circuit organization and
plasticity.
In some instances, and in both compartments, we observed
an SPN spike that occurred within 40–50 ms of the light
application, and sometimes much sooner, raising the possibility
of monosynaptic transmission from ChIs to SPNs. Considering
that evidence is sparse for nicotinic acetylcholine receptor
mediated currents in SPNs (Luo et al., 2013), these responses
could more likely be mediated by glutamate. VGluT3 glutamate
transporters are enriched in subsets of ChIs (Gras et al., 2008;
Stensrud et al., 2013), and glutamate released from ChIs in the
dorsal striatum can induce fast excitatory post-synaptic responses
in striatal interneurons (Luo et al., 2013; Nelson et al., 2014a) and
in SPNs (Higley et al., 2011).
Cholinergic Signaling in the Striosome and
Matrix Compartments Is Disrupted in
Slices Taken from Mice Engaged in
Drug-Induced Stereotypy
Normally, electrically evoked dopamine release is slightly higher
in thematrix than in striosomes (Brimblecombe and Cragg, 2015;
Salinas et al., 2016), but in mice in which striosomal neurons
are identifiable by Nr4a1-GFP, the ratio is reversed by acute
application of cocaine to the brain slices (Salinas et al., 2016).
These findings in striatal slices suggest that cocaine disrupts local
circuits that maintain the baseline striosome-to-matrix ratio of
dopamine signaling. In brain slices from drug-naive rats and
mice, neurokinin 1 (NK1) receptor agonists have differential
effects on evoked dopamine release in the striosomes and matrix,
and these agonist effects are partially affected by cholinergic
blockade (Tremblay et al., 1992; Brimblecombe and Cragg, 2015).
Part of the effect might also be mediated by somatostatin-
containing interneurons (Brimblecombe and Cragg, 2015),
which tend to lie near striosomal borders. The possibility that
striatal interneurons might mediate direct striosome-matrix
communication is further supported by the finding that striatal
injection of an NK1 receptor-coupled toxin ablates ChIs and
somatostatin-positive interneurons and causes a disruption to
the pattern of heightened c-Fos induction in striosomes induced
by dopamine agonists (Saka et al., 2004). We have found that
ChIs do indeed modulate spike-timing of striosomal and matrix
neurons in drug-naive mice and that this modulation is severely
blunted in slices taken from mice treated with a schedule of
D-amphetamine that induces an imbalance in the striosome-to-
matrix ratio of c-Fos expression.
Repeated exposure to psychomotor stimulants strongly
impacts ChI signaling in the dorsal striatum (Wang et al.,
2013), including partial inhibition of nicotinic acetylcholine
receptor mediated dopamine release as measured by fast-
scan cyclic voltammetry in slices (Acevedo-Rodriguez et al.,
2014). This effect may be a compensatory response to over-
stimulation of the dopamine system, considering that ChIs
drive nicotinic acetylcholine receptor mediated dopamine release
(Zhou et al., 2001; Cachope et al., 2012; Threlfell et al., 2012).
Consistently, DHβE application reduces electrically evoked
dopamine release in both striosome and matrix compartments
(Salinas et al., 2016). We confirmed that optogenetic stimulation
induced a spike in ChIs in slices from drug-treated mice,
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but we did not examine whether baseline ChI firing rates
or acetylcholine release were impaired. Thus, whether the
ChI-to-SPN signaling defects are pre- or post-synaptic, or
both, remains to be tested. Regardless of the mechanism, if
semi-synchronized signaling from ChIs to SPNs is important
for responsiveness to salient cues, one consequence of drug-
repressed cholinergic signaling could be a loss of normal
engagement with the environment. When the ChI signaling
across striosome and matrix compartments breaks down under
drug intoxication, behavioral flexibility and cue responsiveness
could be lost.
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